Michael G. Wyllie
Urodoc Ltd
Maryland
Ridgeway Road
Herne
UK
Name/email consistency: low
- Clinical trials for aspiring dummies (and urologists). Wyllie, M.G. BJU Int. (2007)
- Slow progress in prostate cancer. Wyllie, M.G. BJU Int. (2007)
- Left to our own devices. Wyllie, M.G. BJU Int. (2006)
- What's the point?. Wyllie, M.G. BJU Int. (2006)
- Another year, another AUA. Wyllie, M.G. BJU Int. (2006)
- Just hold on a minute (or should it be two?). Wyllie, M.G. BJU Int. (2006)
- The urogynaecologist's perspective. Wyllie, M.G. BJU Int. (2006)
- Just around the corner: effective therapy for Peyronie's disease?. Wyllie, M.G. BJU Int. (2006)
- Have the wheels come off the Asian-Pacific revolution?. Wyllie, M.G. BJU Int. (2006)
- The hunt for pink Viagra. Wyllie, M.G. BJU Int. (2005)
- Two for the price of one?. Wyllie, M. Br. J. Pharmacol. (2005)
- An Asia-Pacific revolution?. Wyllie, M.G. BJU Int. (2005)
- Andropause on the move?. Wyllie, M.G. BJU Int. (2005)
- Back to the future for urological drug development?. Wyllie, M.G. BJU Int. (2005)
- Is urological drug discovery in the doldrums?. Wyllie, M.G. BJU Int. (2005)
- Evergreening: there's life in the old drug yet. Wyllie, M.G. BJU Int. (2005)
- Unseen forces at AUA 2005?. Wyllie, M.G. BJU Int. (2005)
- One drug fits all. Wyllie, M.G. BJU Int. (2005)
- Light at the end of the tunnel for interstitial cystitis?. Wyllie, M.G. BJU Int. (2005)
- Promise for prostatitis?. Wyllie, M.G. BJU Int. (2005)
- Urological flood or drought in 2006?. Wyllie, M.G. BJU Int. (2005)
- Let's hope for more in 2004. Wyllie, M.G. BJU Int. (2004)
- Hormone-based approaches: altering the balance. Wyllie, M.G. BJU Int. (2004)
- Industry and conferences, a parasitic or symbiotic relationship?. Wyllie, M.G. BJU Int. (2004)
- Stress incontinence: help at hand. Wyllie, M.G. BJU Int. (2004)
- Urological research within the pharmaceutical industry: back to basics?. Wyllie, M.G. BJU Int. (2004)
- Fertility under control?. Wyllie, M.G. BJU Int. (2004)
- It's new and exciting--can it be AUA 2004?. Wyllie, M.G. BJU Int. (2004)
- The science (or art?) of new clinical trial designs. Wyllie, M.G. BJU Int. (2004)
- The final dose of clinical trial designs. Wyllie, M.G. BJU Int. (2004)
- The brain leads the way. Wyllie, M.G. BJU Int. (2004)
- Mind over matter: CNS-based approaches to urological diseases. Wyllie, M.G. BJU Int. (2004)
- Gene therapy, urological disease and the pharmaceutical industry. Wyllie, M.G. BJU Int. (2003)
- As we enter the new year, several new drugs will be launched globally. Wyllie, M.G. BJU Int. (2003)
- The phosphodiesterase inhibitor 'war'. Wyllie, M.G. BJU Int. (2003)
- The genesis of a phyto-pharmaceutical industry (Mark II). Wyllie, M.G. BJU Int. (2003)
- ADAM and the andropause. Wyllie, M.G. BJU Int. (2003)
- Uroselectivity: end of the road?. Wyllie, M.G. BJU Int. (2003)
- Libido and desire: join the club?. Wyllie, M.G. BJU Int. (2003)
- Pharmacokinetic fixes for pharmacodynamic deficits. Wyllie, M. BJU Int. (2003)
- The Second International Consultation on Erectile Dysfunction: highlights from the pharmaceutical industry. Wyllie, M.G. BJU Int. (2003)
- Indians to the rescue!. Wyllie, M.G. BJU Int. (2003)
- Androgen-independent prostate cancer: a growth area?. Wyllie, M.G. BJU Int. (2003)
- Female sexual dysfunction. Wyllie, M. Curr. Opin. Investig. Drugs (2002)